Status:
COMPLETED
Non-invasive MRI to Quantify the Effect of Secretin on Pancreatic Blood Flow and Perfusion in Healthy Volunteers
Lead Sponsor:
University of Nottingham
Conditions:
Chronic Pancreatitis
Eligibility:
MALE
18-75 years
Phase:
PHASE1
Brief Summary
Alterations in pancreatic blood have been implicated in pancreatic inflammation and pain. Several modalities have been used to assess pancreatic blood flow although some of these methods are invasive,...
Detailed Description
Background An alteration in pancreatic blood flow may be important in a number of clinical conditions. Reduction of blood flow is seen in patients with acute and chronic pancreatitis and the quantific...
Eligibility Criteria
Inclusion
- Male
- Healthy
- Able to give informed consent
Exclusion
- Current illness
- Contraindications to magnetic resonance imaging
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01452217
Start Date
September 1 2010
End Date
October 1 2011
Last Update
October 14 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Nottingham
Nottingham, Nottinghamshire, United Kingdom, NG7 2UH